Mucosal Open Cavities: Organs Supported by Specific Microbiocenoses Increasing Human Resistance | Chapter 12 | Recent Progress in Microbiology and Biotechnology Vol. 4

 New aspects of safety mechanisms for the human mucosal cavity are under consideration. It has been proposed that mucosal cavities act as mucosal organs on the basis of their own data. Progress in developing thoughts about the identification and binding of glycoconjugates by mucosal organs is reflected. New mucosal organ players were suggested and identified. Probiotic/symbiotic lectins and probiotic/symbiotic microorganisms were included in the system and glycoconjugates were synthetic polymeric multi-valence patterns. Lectins and glycoconjugates (mucin-like or imitating, antigens, polysaccharides and other metabolites of high molecular mass and postbiotics) were suggested to connect to other non-antibody-origin glycoconjugate-recognizing molecules and receptors of the higher hierarchical defence systems of humans. Proposed ideas, techniques, approaches, methods and algorithms endorse the definition and sub-concepts of working ordered mucosal organs identifying and reversibly binding glycoconjugates. The data is useful for the construction of unique pro/synbiotic microbiocenoses ordered by biotope for use in medical biotechnology.

Author(s) Details

Vladimir M. Lakhtin
Department of Medical Biotechnology, G.N. Gabrichevsky Institute for Epidemiology and Microbiology, Moscow, Russia.

Mikhail V. Lakhtin
Department of Medical Biotechnology, G.N. Gabrichevsky Institute for Epidemiology and Microbiology, Moscow, Russia.

Stanislav S. Afanasiev
Department of Medical Biotechnology, G.N. Gabrichevsky Institute for Epidemiology and Microbiology, Moscow, Russia.

Valery Yu. Davydkin

Department of Medical Biotechnology, G.N. Gabrichevsky Institute for Epidemiology and Microbiology, Moscow, Russia.

View Book :- https://bp.bookpi.org/index.php/bpi/catalog/book/359